Corbus Pharmaceuticals Holdings, Inc.

NASDAQ:CRBP

12.08 (USD) • At close December 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 0001.350000000-0.8820.0970.1370.6480.6581.2310.2861.7622.5742.5929.0951.8861.9271.0910.8540.95-2.440.7960.351.2940.3760.7430.3970.3970.3640.170.114000000000
Cost of Revenue 00.20.1520.1480.1530.1580.3640.3740.3750.370.3680.2348.31611.26510.72116.1127.52330.68623.94823.48822.15222.18121.78415.78112.80810.269.7652.445.6235.7646.3665.384.3163.5672.1741.8231.6351.7070.7230.5720.4530.1690.0620000
Gross Profit 0-0.2-0.1521.202-0.153-0.158-0.364-0.374-0.375-0.37-0.368-1.116-8.218-11.129-10.073-15.452-26.292-30.4-22.186-20.914-19.5626.913-19.898-13.854-11.717-9.406-8.815-4.88-4.826-5.413-5.072-5.004-3.573-3.17-1.777-1.459-1.464-1.594-0.723-0.572-0.453-0.169-0.0620000
Gross Profit Ratio 0000.8900000001.265-84.444-81.494-15.549-23.476-21.365-106.164-12.591-8.127-7.5540.238-10.552-7.188-10.741-11.019-9.2752-6.061-15.459-3.921-13.322-4.812-7.994-4.481-4.005-8.591-14.024000000000
Reseach & Development Expenses 10.8086.8655.7616.986.554.24913.3886.2434.1082.53.2865.7648.69611.26510.72116.1127.52330.68623.94823.48822.15222.18121.78415.78112.80810.269.7658.2875.6235.7646.3665.384.3163.5672.1741.8231.6351.7070.7230.5720.4530.1690.062-0.0150.0290.1780
General & Administrative Expenses 4.6974.1233.8613.1232.9373.943.9094.5544.0734.845.2314.2355.2775.5725.3415.367.6827.7397.6996.2765.5345.2086.6253.7373.1812.9883.052.5752.1311.8782.382.5681.7611.0211.111.0420.7910.9690.8120.6870.3660.2950.0440.2920.0160.0180
Selling & Marketing Expenses 0-0.2-0.152-0.1480000000000000000000000000000000000000000000
SG&A 4.6973.9233.712.9752.9373.943.9094.5544.0734.845.2314.2355.2775.5725.3415.367.6827.7397.6996.2765.5345.2086.6253.7373.1812.9883.052.5752.1311.8782.382.5681.7611.0211.111.0420.7910.9690.8120.6870.3660.2950.0440.2920.0160.0180
Other Expenses 00.6952.9092.760.2180.1830.230.2760.078-0.209-0.1930.1112.033-0.228-0.01513.266-0.005000.4734.10900000000000000000000000000
Operating Expenses 15.50510.7889.4719.9559.4888.18917.29710.7978.1817.348.5179.99813.97316.83816.06221.47135.20538.42531.64729.76427.68627.38928.40819.51815.98913.24712.81510.8627.7537.6428.7467.9486.0764.5883.2842.8652.4252.6761.5351.2590.8180.4640.1060.2760.0450.1970
Operating Income -15.505-10.988-9.623-10.103-9.488-8.189-17.297-10.797-8.181-12.34-8.517-9.998-13.875-16.701-15.414-20.812-33.974-38.139-29.885-27.19-25.0971.705-26.523-17.591-14.898-12.394-11.865-10.862-6.957-7.292-7.453-7.572-5.334-4.192-2.887-2.501-2.255-2.563-1.535-1.259-0.818-0.464-0.106-0.276-0.045-0.196-0
Operating Income Ratio 000-7.485000000011.34-142.571-122.3-23.794-31.62-27.607-133.191-16.96-10.565-9.6910.059-14.065-9.127-13.657-14.519-12.4844.451-8.736-20.822-5.761-20.157-7.183-10.569-7.28-6.865-13.229-22.552000000000
Total Other Income Expenses Net 1.7220.9912.7242.082-0.565-0.595-0.448-0.082-0.6-5.909-0.92-0.26211.699-0.437-0.65112.2-0.9210.0330.2280.614.3060.4470.2880.2850.2970.3240.170.168-0.009-0.005-0.0130.002-0.0130.002-0.0050.0020.0010-0-0.0010.159-0.04-0.01-0.014-0.014-0.013-0
Income Before Tax -13.783-9.997-6.899-8.021-10.053-8.784-17.745-10.879-8.782-13.249-9.437-10.261-2.176-17.138-16.065-8.612-34.895-38.105-29.657-26.581-20.7912.153-26.235-17.306-14.601-12.069-11.695-10.694-6.966-7.297-7.465-7.57-5.347-4.189-2.892-2.499-2.254-2.563-1.536-1.26-0.66-0.505-0.116-0.29-0.06-0.209-0
Income Before Tax Ratio 000-5.943000000011.637-22.36-125.503-24.799-13.084-28.356-133.074-16.831-10.329-8.0280.074-13.913-8.979-13.385-14.139-12.3054.382-8.747-20.837-5.771-20.151-7.2-10.563-7.293-6.859-13.223-22.55000000000
Income Tax Expense 00000.8280.7780.9430.0660.19411.6091.6472.0930.3340.210.6360.6360.916-0.494-0.228-0.542-0.197-0.447-0.288-0.44-0.297-0.324-0.17-0.1680.0090.0050.013-0.0020.013-0.0020.0060.0010.0010.0010.0010.0010.0010.0110.0110.0140.009-0.013-0
Net Income -13.783-9.997-6.899-8.021-10.053-8.784-18.688-10.945-8.976-24.858-11.084-10.261-2.176-17.138-16.065-8.612-34.895-38.105-29.657-26.581-20.7912.153-26.235-17.306-14.601-12.069-11.695-10.694-6.966-7.297-7.465-7.57-5.347-4.189-2.892-2.499-2.254-2.563-1.536-1.26-0.66-0.505-0.116-0.29-0.06-0.209-0
Net Income Ratio 000-5.943000000011.637-22.36-125.503-24.799-13.084-28.356-133.074-16.831-10.329-8.0280.074-13.913-8.979-13.385-14.139-12.3054.382-8.747-20.837-5.771-20.151-7.2-10.563-7.293-6.859-13.223-22.55000000000
EPS -1.15-3.55-2.45-1.81-2.27-2.05-4.47-2.62-2.15-5.96-2.66-2.46-0.52-4.42-4.14-2.96-12.79-15.47-12.84-12.33-9.650.9-12.76-9.07-7.66-6.33-6.22-5.96-4.16-4.36-4.83-5.12-3.66-3.24-2.31-1.99-1.94-2.86-1.78-1.46-0.77-0.59-0.13-0.34-0.069-0.49-0.29
EPS Diluted -1.15-3.55-2.45-1.81-2.27-2.05-4.47-2.62-2.15-5.95-2.66-2.46-0.52-4.42-4.14-2.96-12.79-15.47-12.84-12.33-9.650.9-12.76-9.07-7.66-6.33-6.22-5.69-4.16-4.36-4.83-4.9-3.66-3.24-2.31-1.99-1.94-2.86-1.78-1.46-0.77-0.59-0.13-0.34-0.069-0.49-0.29
EBITDA -13.25-9.145-9.471-9.956-9.137-8.031-17.115-10.612-7.991-7.148-8.321-9.495-13.013-16.316-14.994-20.53-33.772-37.678-29.199-26.633-24.9392.005-26.37-17.436-14.766-12.269-11.783-10.797-6.83-7.259-7.421-7.542-5.313-4.172-2.87-2.483-2.24-2.557-1.529-1.254-0.813-0.493-0.105-0.276-0.045-0.013-0
EBITDA Ratio 000-7.376000000011.361-138.866-120.62-23.155-31.033-26.951-133.263-16.772-10.56-9.5440.069-13.912-9.148-13.562-14.441-12.3624.439-8.512-20.698-5.725-20.083-7.136-10.514-7.234-6.813-13.137-22.493000000000